Neon licenses gene therapy IP from Netherlands Cancer Institute

In October, immuno-oncology company Neon Therapeutics Inc. (Cambridge, Mass.) exclusively licensed IP and know-how from the Netherlands Cancer Institute (Amsterdam, the Netherlands) to develop preclinical gene therapy candidate NEO-PTC-01...